This release is available in French .
Ten McGill University researchers received an important boost today, by way of the announcement of $1.7 million in new funding awarded through the Canada Foundation for Innovation's Leaders Opportunity Fund. "CFI investments are critical for our research leaders, to ensure that their research remains innovative and second to none," said Dr. Rima Rozen, Interim Vice-Principal (Research and International Relations) at McGill.
The McGill projects range from important work in cancer research to the study of bone degeneration in the spine.
The funds are part of a total $27.9 million announced by the Canada Foundation for Innovation (CFI) to support 118 projects at 32 institutions across Canada. Of that amount, $21.4 million was awarded under the Leaders Opportunity Fund – a program designed to provide infrastructure and help Canadian institutions attract and retain top researchers.
"We can say with conviction that Canada is becoming a place where world-class researchers want to be," said Dr. Eliot Phillipson, President and CEO of the CFI, an independent corporation created by the Government of Canada to fund research infrastructure at Canadian universities, colleges, research hospitals and non-profit research institutions. "This CFI investment will further develop Canada's global reputation as a place where outstanding research and training is being conducted."
The McGill research projects are:
Dr. Petra Rohrbach
Dissecting Development and Drug Resistance Mechanisms in Plasmodium Falciparum Using Live Cell Imaging Techniques
$221,873
Dr. Yojiro Yamanaka
Epithelial Morphogenesis in Early Development and Cancer
$120,000
Dr. Danielle Malo
Functional and Comparative Genomics of the Interaction of the Host with Salmonella $270,941
Dr. Lisbet Haglund
Identification, Generation and Repair of Intervertebral Disc Degeneration
$100,000
Dr. Eric Galbraith
Integrated Earth System Dynamics Laboratory
$103,600
Dr. Aaron Sprecher
Laboratory for Integrated Prototyping and Hybrid Environments (LIPHE)
$362,562
Dr. Koren Mann
Mechanisms of Metal-Induced Toxicity
$100,000
Dr. Nancy Braverman
Molecular and Therapeutic Studies in Peroxisome Biogenesis Disorders
$140,000
Dr. Josie Ursini-Siegel
Role of ShcA in the Establishment of a Productive Tumor Microenvironment that Facilitates Breast Cancer Progression
$120,000
Dr. Dao Nguyen
The Study of Pseudomonas Aeruginosa Biofilm and Antibiotic Tolerance
$140,000
On the Web: www.innovation.ca
Contact:
William Raillant-Clark
Media Relations
McGill University
514-398-2189
william.raillant-clark@mcgill.ca
Yves Melanson
Coordinator, Media Relations
Canada Foundation for Innovation
Tel.: 613-996-3160
Cell.: 613-447-1723
yves.melanson@innovation.ca